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ABSTRACT
Background: Vaccination is a widely used strategy for
disease control in cattle in the UK and abroad. However,
there has been limited research describing the uptake and
use of cattle vaccines on UK farms.
Aim: To describe the current uptake and usage of cattle
vaccines in the UK.
Design: A questionnaire, available in paper and online
format, was distributed to cattle farmers by convenience
sampling.
Participants: All UK cattle farmers were eligible to
participate in the study.
Results: Eighty-six per cent of respondents (n=229/266)
had vaccinated their cattle in the past year. Diseases most
commonly vaccinated against were Bovine Viral Diarrhoea,
Leptospirosis and Infectious Bovine Rhinotracheitis.
Vaccination compliance was limited in certain areas, for
example only 48 per cent of respondents stated that they
administered the second dose in the primary course within
the recommended timeframe, and 14 per cent of
respondents stated that they vaccinated earlier than the
youngest recommended age. Although outside the scope
of this study, further work is needed to establish the extent
of inadequate compliance and the effect this has on
vaccine efficacy. The role of the veterinarian was
highlighted as the main supplier of vaccines and preferred
source of vaccination information. Respondents preferred
to receive recommendations regarding vaccination by face-
to-face communication with the veterinarian.
Conclusions: The results provide a description of the
current uptake and usage of cattle vaccines in the UK.
Uptake is generally high but there are areas of usage of
vaccines which could be improved upon. The veterinarian
plays a key role as supplier of vaccines and a source of
information for the majority of farmers. Although outside
the scope of this study, further work is needed to establish
the extent of inadequate compliance and the effect this has
on vaccine efficacy. Although the respondents in this study
represent a biased population of farmers, the findings
indicate areas for future investigation in order to improve
vaccination strategies in cattle in the UK.
INTRODUCTION
Vaccines have been used in veterinary medi-
cine since the inoculation of lambs with sheep
pox in the 16th century (McVey and Shi
2010). The administration of vaccines is now
commonplace and is considered one of the
most important aspects of global disease
control (Tizard 2009). Strategic implementa-
tion of vaccination is important to cattle health
and welfare, as vaccination can help to control
and eradicate disease, as demonstrated by the
global eradication of rinderpest (Normile
2008), and control of rabies, foot and mouth
disease and swine erysipelas (Lombard and
others 2007). In order for disease control to
be effectively achieved via vaccination, correct
usage is required, which includes administer-
ing vaccines via the correct route, at the appro-
priate time and to a speciﬁed target group of
animals (Responsible Use of Medicines in
Agriculture Alliance (RUMA) 2012). Incorrect
administration may lead to breakthrough
disease, rendering vaccination a wasteful,
rather than beneﬁcial exercise (Salisbury and
others 2006).
In the UK, vaccination may be carried out
by anybody who is deemed capable by the
person prescribing the vaccine. The person
prescribing is a veterinarian, pharmacist or a
‘suitably qualiﬁed person’ (SQP), depending
on whether the vaccine is categorised as a
POM-V (Prescription Only Medicine –
Veterinarian) or POM-VPS (Prescription
Only Medicine – Veterinarian, Pharmacist or
SQP). The RUMA initiative provides guid-
ance to farmers on correct vaccination proto-
cols (RUMA 2012).
Each disease presents its own challenges,
and therefore, the decisions on which
animals to vaccinate and which vaccines to
use are multifactorial. Cost, logistical factors
and side effects of vaccination need to be
balanced with the potential beneﬁts of
improved animal health and increased pro-
duction. Factors such as worker health and
safety and farm assurance requirements may
also inﬂuence the decision whether to
vaccinate.
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There is limited information in the literature about
the uptake and usage of vaccination in cattle. A
UK-based study on Bovine Viral Diarrhoea virus (BVDv)
vaccine use suggested that uptake and correct adminis-
tration may be poor, and administration protocols may
not be correct; one-third of farmers never referred to
the vaccine product datasheet, and 48 per cent of
farmers administered the two doses in the primary vac-
cination course at the incorrect interval (Meadows
2010).
The objective of this study was to gather data on the
current usage and uptake of cattle vaccination in the UK
using a farmer survey.
MATERIALS AND METHODS
Questionnaire
A questionnaire was developed and distributed to UK
farmers between September and November 2011 (avail-
able on request form authors). A paper version of the
questionnaire was produced, and an identical online
version was created using a proprietary survey tool
(SurveyMonkey, Palo Alto, USA).
The questionnaire was split in two parts: part A, involv-
ing questions about vaccination protocols on the farm,
and part B, involving questions relating to the respond-
ent and their farm. The questionnaire contained 14
closed and 9 open-ended questions and took approxi-
mately 10 minutes to complete. Eleven questions asked
respondents about the protocol used for a speciﬁc
vaccine the respondent nominated as being most famil-
iar with. As protocols vary between vaccines, the inter-
pretation of ‘correct’ or ‘incorrect’ use was made using
information provided on the vaccine datasheet
(National Ofﬁce of Animal Health (NOAH) 2010).
Pretesting of the questionnaire was carried out with
two veterinary students, four veterinarians and three
farmers. Minor corrections were made, and paper copies
for piloting were sent to ﬁve farmers. The online version
was piloted with two veterinary students and two
farmers. After minor typographical and lay-out adjust-
ments following feedback from pilot participants, the
questionnaire was ﬁnalised for distribution, and a cover
letter included explaining the purpose of the study and
offering the option of entering into a £100 prize draw
for agricultural stockist vouchers.
Farmers were asked to nominate which vaccines they
had used in the past year, aided by images of the vac-
cines which were broadly categorised according to the
diseases they target (Table 1). Multivalent vaccines, pro-
viding protection against more than one disease, were
placed in multiple categories. All vaccines registered for
use in cattle in the UK were included in the survey.
Bluetongue vaccines and one BVDv vaccine were
excluded from the survey, because at the time the ques-
tionnaire was distributed, bluetongue vaccination was
not permitted, and a BVDv vaccine (Pregsure BVD,
Pﬁzer) had recently been taken off the market.
Distribution
The target population was any person in the UK who
owned or worked with cattle. Between September and
November 2011, participants were canvassed at events
around the UK, including the Dairy Event and Livestock
Show, Royal Berkshire Show, Dairy Health Events (Dairy
Development Council, Wales), British Mastitis
Conference, Welsh Dairy Show and two local cattle
markets (Melton Mowbray and Market Drayton); these
were selected by convenience sampling (Dohoo and
others 2003). Paper copies were distributed to approxi-
mately 750 cattle farmers at nine agricultural shows and
meetings. Questionnaires were completed at the events,
or farmers were provided with reply address envelopes.
The link to the online questionnaire was distributed
by email to 13 veterinary practices, and to staff and stu-
dents at the School of Veterinary Medicine and Science,
University of Nottingham, for participation or forward-
ing to potential respondents. The 13 practices were
selected by convenience sampling, via contacts estab-
lished at the aforementioned events. The link was also
placed on online fora (British Farming Forum, Farmers
Weekly Interactive, Farmers Guardian, Farming Forum,
The Cattle Site, Young Farmers’ Club) and on two social
networking sites (Facebook and Twitter).
Distribution and publicity regarding the survey was
increased (by publishing information about the study in
their newsletters or requesting participation from
clients) with the help of veterinary practices, pharma-
ceutical companies and associations involved with cattle
farming (XL Vets, British Cattle Veterinary Association,
DairyCo, Animal Health and Veterinary Laboratories
Agency, Department for Environment, Food and Rural
Affairs and dairy processors). Awareness of the study was
further increased through articles in farming and veter-
inary press such as veterinary newsletters, Veterinary
Times, Farmers Guardian, and other online veterinary
fora (www.vetsonline.com).
Statistical analysis
A datasheet was created using Microsoft Excel 2010
(Microsoft, Redmond, USA) and questionnaire
responses manually entered. Ten per cent of the ques-
tionnaires were checked to detect data entry errors; no
errors were observed. Where appropriate, answers to
open questions were categorised by the ﬁrst author into
themes using thematic analysis methodology
(Attride-Stirling 2001).
EpiTools epidemiological calculator (Sergeant 2009)
was used to perform χ2 tests on all biologically plausible
combinations of categorical variables; only signiﬁcant
relationships are reported. Continuous variables (age
and herd size) were divided into three categories based
on the range and distribution of data collected, taking
into account information on age of farm ‘holders’ and
herd size as reported by DEFRA (2011).
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For 15 questions, it was possible to select more than
one answer; in those cases, the cumulative proportions
could exceed 100 per cent.
RESULTS
Respondent demographics
The questionnaire was completed by 266 respondents
between September and November 2011. Peak responses
were observed early in the study period when distribution
at events was greatest. The response rate for the paper-
based questionnaire was estimated at 18 per cent (n=133/
750), with 68 per cent (n=90/133) of questionnaires being
returned by post, and the remainder being completed at
events. A response rate for the online questionnaire could
not be determined, as it was distributed via public
discussion fora. Fifty per cent (n=133/266) of respondents
completed the questionnaire online (Table 2). Non-
respondents were not further investigated.
Vaccine uptake
Eighty-six per cent (n=229/266) of respondents indi-
cated that they had vaccinated their cattle in the past
year, with more dairy farmers vaccinating compared to
TABLE 1: Vaccines licensed for use in cattle in the UK (NOAH 2010)
Disease category or body
system affected* Company Product name Target pathogen/s
Clostridial Intervet Blackleg Clostridium chauvoei
Bravoxin C perfringens types A, B, C, D, C chauvoei, C novyi type
B, C septicum, C sordellii, C haemolyticum, C tetani
Tribovax T C chauvoei, C novyi type B, C septicum, C haemolyticum,
C tetani
Pfizer Blackleg C chauvoei
Covexin 8 C perfringens types B, C, D, C chauvoei, C novyi type B,
C septicum, C haemolyticum, C Tetani
Covexin 10 C perfringens types A, B, C, D, C chauvoei, C novyi type
B, C septicum,C sordellii, C haemolyticum, C tetani
Dermatological Intervet Bovilis Ringvac Tricophyton verrucosum
Enteric Intervet Bovivac S Salmonella dublin, S typhimurium
Rotavec Corona Escherichia coli, coronavirus, rotavirus
Merial Trivacton 6 E coli, coronavirus, rotavirus
Pfizer Lactovac E coli, coronavirus, rotavirus
Mastitis Hipra Startvac E coli, Staphylococcus aureus
Reproductive Intervet Bovilis BVD BVDv
Leptavoid H Leptospira interrogans serovar hardjo, L borgpetersenii
serovar hardjo
Novartis Bovidec BVDv
Pfizer Spirovac L borgpetersenii serovar hardjo
Respiratory Hipra Hiprabovis IBR
Marker Live
IBR (BHV-1)
Hiprabovis Pneumos Mannheimia haemolytica, Histophilus somni
Intervet Bovipast PI3, BRSV, M haemolytica
Bovilis Huskvac Dictyocaulus viviparous
Bovilis IBR Marker
Live
IBR (BHV-1)
Merial Pastobov M haemolytica
Pfizer Imuresp RP PI3, IBR (BHV-1)
Rispoval 3 PI3, BRSV, BVDv
Rispoval 4 PI3, BRSV, BVDv, IBR (BHV-1)
Rispoval IBR Marker
Inactivated
IBR (BHV-1)
Rispoval IBR Marker
Live
IBR (BHV-1)
Rispoval Pasteurella M. haemolytica
Rispoval RS BRSV
Rispoval RS + PI3
Intranasal
BRSV, PI3
Tracherine IBR (BHV-1)
*Pathogens are categorised by the primary target of the vaccine, however, certain pathogens may affect more than one body system
BHV-1, Bovine Herpesvirus-1; BRSV, Bovine Respiratory Syncytial Virus; BVDv, Bovine Viral Diarrhoea Virus; IBR, Infectious Bovine
Rhinotracheitis; PI3, Parainfluenza-3
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beef farmers (Table 3). The most frequent reason for
not vaccinating was that they did not perceive there to
be a problem that required vaccination (65 per cent).
Respondents from large farms (>160 adult cattle) were
more likely to have vaccinated their cattle in the past
year than respondents from small farms (<81 cows)
(P=0.005). The difference in vaccination uptake
between small or large, versus average size farms was not
signiﬁcant in the χ2 analysis. As 37 respondents indi-
cated that they did not vaccinate (Table 3), only a
maximum of 229 respondents could complete the ques-
tions on vaccine usage. The number of total responses
for each question varied, which has been indicated in
relevant Tables and Figures.
The highest uptake of vaccination, for dairy as well as
beef, was for BVDv vaccination, and there was a notice-
able difference in uptake of lungworm vaccine between
dairy and beef respondents (Fig 1). Uptake for other
vaccines was: 19 per cent for rotavirus, coronavirus and
Escherichia coli (Trivacton 6, Rotavec Corona and
Lactovac), 9 per cent for salmonellosis (Bovivac S),
6 per cent for ringworm (Bovilis Ringvac), and 1 per
cent for mastitis (Startvac).
Vaccine usage
Speciﬁc questions were asked about usage of the vaccine
that respondents had selected as the one they were most
familiar with. Thirty-three per cent of respondents
excluded certain animals from vaccination (Table 4).
When prompted for further information, 6 per cent of
respondents indicated that they excluded pregnant
animals, of which two respondents stated using a clos-
tridial vaccine that is not recommended for use in
animals in the ﬁrst and second trimesters of pregnancy.
Fifty respondents stated that they used a vaccine which is
not recommended for pregnant animals, but did not
nominate any exclusions. Sixteen of these 50 respon-
dents were dairy farmers, 12 of whom indicated that
they vaccinated calves up to six months, which may
explain why they did not state to exclude pregnant
animals from vaccination.
TABLE 2: Information about questionnaire respondents overall and specified for dairy and beef respondents. Variance in
denominators relates to questions not filled in by respondents
Respondent type
% (n)* Dairy % (n) Beef % (n)
Gender
Male 82 (180/220) 88 (95/108) 76 (70/92)
Female 18 (40/220) 12 (13/108) 24 (22/92)
Role on farm†
Senior (e.g., owner, herdsman, herd manager) 74 (164/222) 74 (84/113) 77 (68/88)
Junior (e.g., worker) 26 (58/222) 26 (29/113) 23 (20/88)
Farm size†
Small (<81 adult cattle) 35 (77/219) 10 (11/114) 69 (59/86)
Medium (81–160 adult cattle) 29 (63/219) 36 (41/114) 21 (18/86)
Large (>160 adult cattle) 36 (79/219) 54 (62/114) 10 (9/86)
Age
Less than 30 years 26 (59/227) 23 (26/114) 27 (25/92)
31–50 years 46 (104/227) 52 (59/114) 43 (40/92)
51 years or over 28 (64/227) 25 (29/114) 29 (27/92)
Highest level of education
School education 25 (56/226) 26 (29/113) 21 (19/91)
Further education (e.g., OND, HND, NDA) 49 (111/226) 51 (58/113) 47 (43/91)
Higher education (e.g., BSc, MSc) 26 (59/226) 23 (26/113) 32 (29/91)
Response format
Online 50 (133/266) 29 (33/114) 64 (59/92)
Post 50 (133/266) 71 (81/114) 36 (33/92)
Location
North England 10 (22/224) 12 (13/111) 11 (10/92)
South England 31 (69/224) 31 (34/111) 27 (25/92)
Midlands 20 (45/224) 25 (28/111) 14 (13/92)
Wales 31 (69/224) 30 (33/111) 29 (27/92)
Scotland and Northern Ireland 8 (18/224) 2 (2/111) 18 (17/92)
Estimated milk yield (litres/cow/year)
Range 4700 to 10,700
Mean (median) 7733 (8000)
*Includes dairy, beef, mixed and unallocated respondents
†Data derived from open questions with responses grouped using thematic analysis methods
HND, Higher National Diploma; NDA, National Diploma of Agriculture; OND: Ordinary National Diploma.
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The youngest age at which animals were nominated as
ﬁrst receiving a vaccine ranged from one week to
36 months. Of those respondents who had speciﬁed the
vaccine they were most familiar with, 14 per cent were vac-
cinating earlier than the youngest recommended age
(Table 4). Vaccines administered too early were against
BVDv (n=6), lungworm (n=3), Infectious Bovine
Rhinotracheitis (IBR) (n=2), respiratory disease complexes
(n=2), clostridial diseases (n=2) and leptospirosis (n=1).
After the ﬁrst dose was given, 48 per cent of respon-
dents were administering a second dose of the vaccine
‘correctly’ (i.e., at the recommended time, or not at all if
not required). A second dose of vaccine was most com-
monly administered within the correct time frame for
lungworm vaccines (64 per cent), and least commonly
administered within the correct time frame for vaccines
against clostridial diseases (17 per cent) (Table 5).
Several verbal and two written comments provided at the
end of the questionnaire raised issues regarding the
‘inconvenience of vaccines requiring two doses’.
Seventy-three per cent of farmers stated the correct
route of administration for the nominated vaccines (intra-
muscular, subcutaneous, intranasal or oral routes).
Frequently mentioned incorrect routes were subcutaneous
where intramuscular was indicated (17 per cent, n = 11/
64) and vice versa (13 per cent, n = 10/75). For those vac-
cines where an injection site was recommended on the
datasheet, 69 per cent of respondents nominated the
recommended site (Table 4). Of those respondents not
injecting at the recommended site, 46 per cent were inject-
ing in the gluteal region where the neck was recom-
mended, and 42 per cent were injecting elsewhere on the
animal. The remainder of incorrect answers (12 per cent)
indicated more than one injection site. A recommended
site for injection was not provided on the datasheet for 12
vaccines; these were excluded from the analysis (n=77).
Vaccines were, on the majority of farms, administered
by workers. Twenty-three per cent of respondents did
not read instructions as ‘they did what they had done
previously and did not need instructions’ (Table 4).
Eight per cent of respondents obtained the vaccine
from an agricultural merchant (Table 4), the majority of
which were legal category POM-VPS. Three respondents
obtained vaccines from an agricultural merchant which
required a veterinary prescription (POM-V). Sixty-six per
cent of respondents indicated that they or somebody
else on the farm had discussed the use of the vaccine
with the person who had supplied it in the past year,
and cost was the most common topic for dairy as well as
beef farmers (Table 3).
Knowledge transfer
Most respondents (94 per cent) sourced information
regarding vaccinating cattle from their veterinarian
TABLE 3: Questionnaire responses regarding farmers’ uptake, motivation and communication regarding vaccination of
cattle in the UK
Respondent type
Total*% (n) Dairy % (n) Beef % (n)
Have you vaccinated your cattle in the past year?
Yes 86 (229/266) 95 (107/113) 79 (73/92)
No 14 (37/266) 5 (6/113) 21 (19/92)
Motivation to vaccinate†
Losses 49 (88/180) 52 (50/96) 50 (35/70)
Veterinary advice 26 (47/180) 25 (24/96) 29 (20/70)
To control disease 15 (27/180) 8 (8/96) 20 (14/70)
Disease testing/monitoring 12 (22/180) 18 (17/96) 4 (3/70)
Requirement for shows/sales 5 (9/180) 0 (0/96) 11 (8/70)
Have always used 3 (5/180) 5 (5/96) 1 (1/70)
Motivation not to vaccinate†
Did not perceive there to be a problem 65 (17/26) 50 (3/6) 71 (12/17)
Tests were found to be negative 15 (4/26) 33 (2/6) 12 (2/17)
Closed herd 11 (3/26) 17 (1/6) 12 (2/17)
Cost 15 (4/26) 33 (2/6) 12 (2/17)
Did you discuss use of the vaccine with your supplier in the last year?
Yes 66 (129/195) 65 (69/106) 69 (50/72)
If yes, what was discussed?†
Cost 46 (59/129) 52 (36/69) 42 (21/50)
Individual farm advice 36 (46/129) 35 (24/69) 33 (17/50)
Procedure 31 (40/129) 32 (22/69) 31 (15/50)
Efficacy 11 (14/129) 10 (7/69) 13 (7/50)
Other products/availability 10 (13/129) 7 (5/69) 15 (8/50)
Risks 1 (1/129) 0 (0/69) 2 (1/50)
*Includes dairy, beef, mixed and unallocated respondents
†Data derived from open questions with responses grouped using thematic analysis methods
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(Fig 2). When asked for their preferred source of infor-
mation, 95 per cent of respondents preferred to receive
information about vaccination from a veterinary prac-
tice, with the majority of respondents preferring
face-to-face communication. Email, websites and mobile
telephone were more often preferred by beef farmers
compared to dairy farmers (Fig 3).
DISCUSSION
This survey describes novel information on vaccine
usage in the UK that could be beneﬁcial to practitioners
implementing vaccination protocols on farms.
Many farmers who did not use cattle vaccines did not
perceive there to be a problem with disease on their
farm, although few stated that they had actively moni-
tored disease. The risk of introducing disease in naive
herds can be high, particularly when buying in livestock.
Improved immunity through vaccination may reduce the
risk of losses (Stott and Gunn 2008).
Datasheets for most vaccines recommend that
unhealthy animals should be excluded from vaccination,
as vaccinating immunocompromised animals may lead
to ineffective protection. In this survey, only a minority
of farmers were excluding certain animals, including
sick and injured cattle, and this could lead to less than
adequate disease control. Additionally, 50 respondents
who nominated using a vaccine which was contraindi-
cated in pregnant cattle did not state they would
exclude these animals from being vaccinated. This may
FIG 1: Distribution of vaccines
used by respondents (Dairy
n=114, Beef n=92) by disease
category
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be due to farmers being unaware of the risks of using
these vaccines in pregnant animals, but may also be
because there were no pregnant cattle on these farms,
which is likely for respondents from beef farms with
grower and/or ﬁnisher herds. Other reasons for not
excluding animals could be that a whole herd approach
is being taken for management purposes, and all
animals are being vaccinated, rather than selecting
animals individually for vaccination.
Timing of vaccination may also be important for
effective disease control, and the majority of respon-
dents administered vaccines within the recommended
timeframe on the datasheets. This was carried out cor-
rectly more frequently for ﬁrst vaccinations (86 per
cent) than for the second dose within a primary course
(48 per cent). Vaccine failure has been demonstrated in
human beings where administration occurred below the
recommended ﬁrst age of vaccination (Galil and others
2002), and by not administering a second dose within
the recommended time period (Peltola and others
1994). Although these studies involve human patients,
immunological responses to vaccines have been shown
to be similar between bovine and human patients, as
described in a study investigating immunological pro-
cesses of tuberculosis in human beings and cattle
(Waters and others 2011). This suggests that not admin-
istering vaccines to cattle within the recommended time-
frame may lead to vaccine failure.
The most common incorrect route of administration
was the use of subcutaneous versus intramuscular injec-
tions. A study in human patients demonstrated that the
same vaccine is immunogenic regardless of whether it is
injected subcutaneously or intramuscularly (Knuf and
others 2010). There is no data to support this ﬁnding in
the veterinary literature with regards to vaccines.
However, for other veterinary medicines, such as iver-
mectin and ceftiofur sodium, the efﬁcacy of the drug
was not deemed to be different when using intramuscu-
lar versus subcutaneous routes of administration
(Lifschitz and others 1999, Brown and others 2000).
Understanding farmer motivators and barriers for vac-
cination may be useful to improve uptake and usage of
vaccines. Economic factors, such as vaccine cost and
increased production proﬁts associated with vaccination,
could affect decision-making on whether to vaccinate.
Although nearly half the respondents had discussed cost
TABLE 4: Questionnaire responses regarding the usage of vaccines by cattle farmers in the UK
Respondent type
Total*% (n) Dairy % (n) Beef % (n)
Do you exclude animals from vaccination?
Yes 33 (64/195) 34 (36/106) 31 (22/72)
Which animals are excluded from vaccination?
Sick/injured animals 21 (14/66) 19 (7/37) 18 (4/22)
Pregnant animals 6 (4/66) 3 (1/37) 9 (2/22)
Lactating animals 2 (1/66) 3 (1/37) 0 (0/22)
Animals to be reared for beef 29 (19/66) 30 (11/37) 27 (6/22)
Animals to be sold in the next 12 months 32 (21/66) 38 (14/37) 32 (7/22)
Other 29 (19/66) 22 (8/37) 45 (10/22)
What is the youngest age at which animals first receive this vaccine?
Vaccinating earlier than recommended age† 14 (16/116) 9 (6/69) 15 (6/39)
What route of administration did you use?‡
Recommended route† 73 (128/175) 77 (69/90) 73 (49/67)
If using an intramuscular or subcutaneous route, which injection site did you use?
Recommended site† 69 (57/82) 67 (28/42) 70 (26/37)
What instructions did you follow?
On the bottle/box/label 61 (119/195) 58 (61/105) 61 (44/72)
On the datasheet 33 (64/195) 31 (33/105) 40 (29/72)
I did what I have done previously and did not need Instructions 23 (45/195) 24 (25/105) 21 (15/72)
Vaccine supplier 16 (31/195) 15 (16/105) 18 (13/72)
Who supplied the vaccine?§
Veterinary practice 93 (174/187) 95 (96/101) 89 (64/72)
Agricultural merchant 8 (15/187) 7 (7/101) 10 (7/72)
Internet company 1 (2/187) 1 (1/101) 1 (1/72)
Person administering vaccine§
Senior position on farm 42 (68/161) 42 (36/85) 42 (25/60)
Worker 61 (98/161) 65 (55/85) 57 (34/60)
Veterinarian 6 (10/161) 0 (0/85) 15 (9/60)
*Includes dairy, beef, mixed and unallocated respondents
†Recommendations taken from product datasheet (NOAH 2010)
‡Intramuscular, subcutaneous, intranasal or oral
§Data derived from open questions with responses grouped using thematic analysis methods
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with their vaccine supplier in the past year, cost was not
frequently mentioned as a barrier for vaccination.
However, a Dutch study has suggested that economic
factors are the main motivators (e.g., increased produc-
tion proﬁts) and barriers (e.g., vaccination costs) for
farmers when deciding whether to vaccinate their live-
stock (Elbers and others 2010). Other studies describe
factors, such as worker satisfaction, as being equally as
motivating as cost in farmer decision-making about
cattle health (Valeeva and others 2007).
The veterinarian was the main vaccine supplier, and
also the preferred source of information for many
respondents in this study, but only 66 per cent of respon-
dents had discussions about vaccine use with their sup-
plier. The variation observed with respect to following
recommended vaccination protocols may be explained
by this lack of discussion on the use of vaccines.
Incorporating information such as RUMA’s ‘Checklist
for Vaccination’ (RUMA 2012), together with tailored
farm advice during herd health visits provides an oppor-
tunity to discuss vaccination protocols with a client. This
approach could improve adherence to recommended
vaccination strategies, reduce vaccine failure on farms,
and raise awareness of the potential beneﬁts among
those who are not vaccinating.
Veterinarians are valued by farmers as important dis-
cussion partners in the ﬁeld of animal health (Hall and
Wapenaar 2012) and can share expertise in addition to
supplying vaccines. As 21 out of the 31 vaccines available
require a prescription which can only be obtained from
a veterinarian, it may be more convenient for farmers to
obtain information and supplies from the same source,
FIG 2: Distribution of responses
from 112 dairy and 90 beef
farmers when asked ‘Where do
you find information with regards
to vaccinating your cattle?’.
*DairyCo and English Beef and
Lamb Executive Ltd. (EBLEX) are
levy funded organisations for the
UK dairy and beef industry.
**Responsible Use of Medicines
in Agriculture Alliance
TABLE 5: Appropriateness of use of a second dose in
the primary vaccine course within the recommended time
frame* (NOAH 2010) per disease category†
Total % (n)‡ Dairy % (n) Beef % (n)
IBR
Correct* 48 (11/23) 60 (6/10) 33 (4/12)
Incorrect 26 (6/23) 20 (2/10) 33 (4/12)
Don’t know 26 (6/23) 20 (2/10) 33 (4/12)
Respiratory diseases
Correct* 53 (8/15) 75 (3/4) 50 (5/10)
Incorrect 20 (3/15) 0 (0/4) 20 (2/10)
Don’t know 27 (4/15) 25 (1/4) 30 (3/10)
BVD
Correct* 40 (19/47) 55 (11/20) 25 (6/24)
Incorrect 32 (15/47) 35 (7/20) 29 (7/24)
Don’t know 28 (13/47) 10 (2/20) 46 (11/24)
Clostridial diseases
Correct* 17 (3/18) 33 (1/3) 15 (2/13)
Incorrect 50 (9/18) 66 (2/3) 54 (7/13)
Don’t know 33 (6/18) 0 (0/3) 31 (4/13)
Lungworm
Correct* 64 (14/22) 65 (11/17) 100 (1/1)
Incorrect 36 (8/22) 35 (6/17) 0 (0/1)
Don’t know 0 (0/22) 0 (0/17) 0 (0/1)
Leptospirosis
Correct* 60 (23/38) 61 (14/23) 57 (8/14)
Incorrect 24 (9/38) 22 (5/23) 29 (4/14)
Don’t know 16 (6/38) 17 (4/23) 14 (2/14)
*Recommendations taken from datasheet (NOAH 2010)
‡Includes dairy, beef, mixed and unallocated respondents
†Responses for multivalent vaccines (n=8) were incorporated into
multiple disease categories
BVD, Bovine Viral Diarrhoea; IBR, Infectious Bovine
Rhinotracheitis
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as opposed to agricultural merchants and internet phar-
macies. Supplying medicines forms an essential part of
farm veterinary practice in the UK; it was recently
reported that an average of 55 per cent of income for
farm veterinary practices is derived from medicine sales
(Veterinary Development Council 2012). Although vac-
cines are available from agricultural merchants and
internet pharmacies, 93 per cent of respondents bought
their vaccines from a veterinarian, highlighting the
potential opportunity for the veterinarian to combine
their role as supplier with their role as advisor about vac-
cination. Veterinarians rarely carried out vaccination on
farms, as this was mostly done by workers and senior
staff. Generally, no speciﬁc qualiﬁcations are required to
be a farm worker; it may be that some of these workers
carrying out vaccination have had no formal training in
the correct administration of vaccines. Further work to
conﬁrm lack of training as a cause of suboptimal vaccine
usage may help to focus future knowledge transfer
activities.
A limitation of the study was that information provided
by respondents may have differed from reality, particu-
larly when answered from memory (recall bias).
Therefore, incorrect answers may have been provided by
respondents who, in fact, are vaccinating correctly when
able to refer to the recommended protocol. Parts of the
questionnaire responses could not be used for analysis
as answers were not provided for some questions or were
ambiguous. This was particularly apparent where 20
respondents did not nominate a vaccine they were most
familiar with, as a response was required for the correct
interpretation of several of the subsequent questions.
There was no apparent explanation for these missing
responses. Additionally, this study asked questions
regarding the use of one speciﬁc vaccine they felt most
familiar with which may not be representative of the
usage of other vaccines on the farm.
In this study, the proportion of farmers not vaccinating
was likely to be underestimated. Bias due to convenience
sampling is probable; it is likely that farmers who vaccin-
ate their cattle and were interested in vaccination were
more inclined to participate in the survey than those
who did not have any interest in vaccination. However,
the demographic data of respondents, as described in
Table 2, resemble the demographic data collected by
DEFRA on the whole UK farming population (DEFRA
2011), indicating that a reasonably representative cross-
section of farmers participated in the study.
The sample size of 266 respondents limited the power
of this study; increasing the number of respondents to
consolidate our ﬁndings would further support the
study results. However, the farming population in the
UK is known to be challenging to engage in survey-
based research, and increasing sample size will take con-
siderable effort. Our results, although only describing
vaccination uptake and usage of 266 respondents, are
supported by other work performed in the UK
(Meadows 2010) and provide a basis for further studies
to evaluate vaccine efﬁcacy and disease control in situa-
tions with correct and less than ideal use of vaccines. A
perhaps more important limitation of this study is the
bias encountered because of the convenience sampling
method used, which is difﬁcult to counter using the vol-
untary survey method. One could hypothesise that this
study underestimated vaccination compliance, as more
engaged farmers may have participated, which makes it
more likely to expect poorer compliance in non-
respondents. However, as the current published body of
work in the ﬁeld of uptake and usage of cattle vaccines
is scarce, the ﬁndings of this study are important to
describe current usage strategies on vaccination, and are
therefore an important contribution to knowledge in
this ﬁeld.
In conclusion, uptake of cattle vaccines in the UK was
generally good, but improvements to usage would
improve adherence to data sheet guidelines and could
increase the efﬁcacy of vaccination. A particular area
where vaccination strategies could be improved would
FIG 3: Distribution of responses
from 112 dairy and 90 beef
farmers when asked ‘In what
format would you prefer to receive
information about vaccination?’
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be correctly selecting animals for vaccination and
administering vaccines within the recommended time-
frames. The veterinarian was nominated as the main
vaccine supplier and source of information on vaccines
and, therefore, remains crucial to improve cattle vaccin-
ation strategies in the UK.
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